These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 8889607)

  • 21. Need and strategy for sentinel surveillance for drug resistance in leprosy in India.
    Joshi PL; Thorat DM; Manglani PR
    Indian J Lepr; 2009; 81(3):113-8. PubMed ID: 20509338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hidden cases of leprosy (in prison).
    Vijayakumaran P; Mahipathy PV; Misra RK; Petro TS; Ramanujan R; Karunakaran S; Abraham O
    Indian J Lepr; 1997; 69(3):271-4. PubMed ID: 9394177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity.
    Shaw IN; Christian M; Jesudasan K; Kurian N; Rao GS
    Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Case finding survey for leprosy in Botswana.
    Kumaresan JA; Khulumani P; Maganu ET
    East Afr Med J; 1993 Oct; 70(10):635-8. PubMed ID: 8187660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An evaluation of the contribution of the Swedish International Development Authority (SIDA) to leprosy control in India based on the implementation of multiple drug therapy (MDT) 1981-1993.
    Peat M; Brolin L; Ganapati R; McDougall AC; Revankar CR; Watson JW
    Indian J Lepr; 1995; 67(4):447-65. PubMed ID: 8849921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multidrug therapy--the pathway for global leprosy elimination.
    al-Qubati Y; al-Kubati AS
    Indian J Lepr; 2000; 72(4):477-90. PubMed ID: 11212482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NLEP--current situation and strategy during the 11th plan period (2007-2012).
    Dhillon GP
    J Indian Med Assoc; 2006 Dec; 104(12):671-2. PubMed ID: 17474280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malaria, leprosy and dapsone.
    Saha K; Kapoor L; Arora VM; Chattopadhya D
    Southeast Asian J Trop Med Public Health; 2003 Sep; 34(3):501-4. PubMed ID: 15115119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leprosy at a turning point?
    Harboe M
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):312-8. PubMed ID: 11221095
    [No Abstract]   [Full Text] [Related]  

  • 30. Dapsone drug resistance in the MDT era.
    Roche PW; Neupane KD; Failbus SS; Butlin CR
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
    [No Abstract]   [Full Text] [Related]  

  • 31. Screening of registered leprosy cases and its effects on prevalence rate.
    Rao PS; Sirumban P
    Indian J Lepr; 1990; 62(2):180-5. PubMed ID: 2212732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of secondary dapsone resistance in Gudiyattam Taluk, the leprosy control area of the Schieffelin Leprosy Research and Training Centre, Karigiri. 1. Preliminary report.
    Balraj V; Jesudasan K; Chacko CJ; Christian M; Taylor PM; Fritschi EP; Job CK
    Int J Lepr Other Mycobact Dis; 1980 Dec; 48(4):397-401. PubMed ID: 7193654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leprosy control in Zambia.
    Steenbergen GJ
    World Health Stat Q; 1991; 44(1):30-5. PubMed ID: 2068823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deformity incidence in leprosy patients treated with multidrug therapy.
    Rao PS; Subramanian M; Subramanian G
    Indian J Lepr; 1994; 66(4):449-54. PubMed ID: 7714354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leprosy in the WHO African region.
    Daumerie D
    World Health Stat Q; 1991; 44(1):16-22. PubMed ID: 2068820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary dapsone resistance in Cebu, The Philippines; cause for concern.
    dela Cruz E; Cellona RV; Balagon MV; Villahermosa LG; Fajardo TT; Abalos RM; Tan EV; Walsh GP
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):253-6. PubMed ID: 8862258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends in detection of new leprosy cases at two centres in Himachal Pradesh, India: a ten-year study.
    Mahajan VK; Sharma NL; Rana P; Sood N
    Indian J Lepr; 2003; 75(1):17-24. PubMed ID: 15253391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Problems of leprosy relapse in China.
    Li HY
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):1-7. PubMed ID: 8326169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pattern of drug compliance in leprosy patients attending urban centres--a longitudinal study.
    Naik SS; Gole DH; Neet MR; Dongre VV
    Indian J Lepr; 1990; 62(3):305-9. PubMed ID: 2262714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative study of uniform-MDT and WHO MDT in Pauci and Multi bacillary leprosy patients over 24 months of observation.
    Rao PN; Suneetha S; Pratap DV
    Lepr Rev; 2009 Jun; 80(2):143-55. PubMed ID: 19743618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.